CompletedNCT01908205
Intranasal Oxytocin for Children and Adolescents With Autism
About this title
Read the official source — NCT01908205Medication studyAges 10–17United States + CanadaAnxiety
Understand this study
Who was this study for?
Listed age limits: 10 years to 17 years.
- Listed locations
- Minneapolis and 1 more locationSee all locations and recruitment
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
Study information
Study start dateSeptember 2013
- Recruitment status
- Completed
- Enrollment listed in the registry
- 60
- Sponsor
- Holland Bloorview Kids Rehabilitation Hospital
- Sponsor type
- Hospital / academic medical center
- Study type
- Drug
- Intervention type
- Drug
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
- Locations
- United States, Canada
- Age range
- From 10 Years to 17 Years
- Official registry ID
- NCT01908205
- Official title
Show the full official title
Intranasal Oxytocin for the Treatment of Children and Adolescents With Autism
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Minneapolis, United States · Toronto, Canada
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Holland Bloorview Kids Rehabilitation Hospital, a hospital or academic medical center.
Did this study involve medication?
Yes. The study involved medication, including Intranasal Oxytocin and Placebo.
Who was this study for?
Listed age limits: 10 years to 17 years.
